A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

A Ann Marie Navar E Elina Mikhailova (MSD UK, London) A Alberico L. Catapano (University of Milan, Milan) P Puja Banka (MSD, Rahway, NJ) D Dirk J. Blom A Alberto Cadena (Clínica de la Costa, Barranquilla, Colombia) S Susan Kourpanidis (MSD, Rahway, NJ) N Norman E. Lepor (National Heart Institute, Beverly Hills, CA) K Kazuhisa Tsukamoto (Teikyo University School of Medicine, Tokyo) G Geraldine Mendizabal (MSD Argentina, Buenos Aires) J Julio Nunez (University of Valencia, Valencia, Spain) W Wenjuan Zhang P Pengfei Zhu (MSD China, Shanghai) M Min Zhuo (MSD, Rahway, NJ) C Christie M. Ballantyne (Texas Heart Institute at Baylor College of Medicine, Houston)